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No Correlation Between Changes in Fatty
Acid-binding Protein Content and Fatty Acid
Oxidation Capacity of Rat Tissues in Experimental 
Diabetes
J. H. VEERKAMP,* H. T. B. VAN MOERKERK, J. VAN DEN BORN
Departments of Biochemistry and Nephrology, University o f  Nijmegen, Nijmegen, The Netherlands
Fatty acid-binding protein is considered to play an important role in fatty acid oxidation. Since 
diabetes mcllitus causes marked changes of this latter metabolic process, we compared the effect 
of this pathological condition on both parameters in a comparative investigation of different rat 
tissues. Palmitate oxidation capacity and content of fatty acid-binding protein were determined 
in liver, heart and quadriceps muscle from rats with 2-week streptozotocin-induced diabetes 
mcllitus and controls. In liver homogenates fatty acid oxidation capacity increased by 90%, but 
their content of fatty acid-binding protein decreased by 35%. Fatty acid oxidation capacity of 
heart and quadriceps muscle and fatty acid-binding protein content of quadriceps muscle did not 
change, but fatty acid-binding protein content of heart muscle doubled. Long-term diabetes (8 
months) had a similar elfcct on content of this protein. In summary, changes of fatty acid 
oxidation capacity do not appear to correlate with fatty acid-binding protein content during the 
development of diabetes. This does not preclude other functions of fatty acid-binding proteins in 
regulation of lipid metabolism and processes in which fatty acids play a modulatory role. 
Copyright (.n 1996 Elsevier Science Ltd.
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INTRODUCTION and impair together with insulin lack myocar­
dial glucose oxidation (Randle et aL, 1988; 
Diabetes mellitus represents a serious disturb- Saddik and Lopaschuk, 1994; Wall and
ance of homeostasis of glucose and fatty acid Lopaschuck, 1989). These changes are closely 
metabolism in many tissues o f  the body. The linked to the accumulation o f various acyl-Co A 
absence o f  insulin in insulin-dependent diabetes and acylcarnitine esters (Feuvray et aL, 1979). 
mellitus of man and strcptozotocin-induccd The heart of the diabetic rat applies almost 
diabetes of rats causes an abnormal high lipoly- entirely fatty acid oxidation as its source of 
sis leading to very high plasma free fatty acid ATP, but oxidation of exogenous and endogen­
ous palmitate was not elevated (Wall and 
Lopaschuk, 1989). Fatty acid oxidation is 
increased in perfused muscle of diabetic dogs 
(Spitzer and Hori, .1969) and incubated
levels (McGarry, 1994). Glucagon action on the 
liver, in the absence o f  restraint by insulin, 
activates by a decrease of malonyl-CoA content 
hepatic carnitine aeyltransferasc 1 and in this
way hepatic fatty acid oxidation and ketogene- diaphtagm of diabetic tats (Steams et aL, 1979). 
sis (McGarry and Foster, 1980). The high levels Fa“ y ^id-binding proteins (FABP) are sup- 
of plasma free fatty acids appear to increase P°sed t0 P1^  an important role m the cellular
triacylglycerol synthesis in the diabetic heart
*To whom all correspondence should be addressed 
Abbreviation; 1;ABI\ fully acid-binding protein. 
Received 1 August 1995; accepted 4 October 1995.
uptake and targeting of fatty acids (Veerkamp 
et aL, 1993; Veerkamp, 1995). A relation 
between fatty acid oxidation capacity and 
cytosolic FABP content appears to exist in heart 
and various muscles of man and rat (Peeters
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et a l, 1989). The same was observed for various 
tissues of control and clofibrate-treated rats 
(Glatz et a l , 1988). Other tissues as brain and 
adrenals do not show this relation, presumably 
due to involvement of FABP in other pathways 
of fatty acid metabolism (Veerkamp and Van 
Moerkerk, 1993). Rat liver showed concurrent 
changes at treatment with peroxisomal prolifer- 
ators and high-fat diet and with sex, but 
not during postnatal development and at 
starvation (Veerkamp and Van Moerkerk, 
1993). Heart and skeletal muscle FABP content 
increase at postnatal development, but are 
stable in most physiological conditions investi­
gated (Veerkamp and Van Moerkerk, 1993).
weight) were made diabetic by i.v. injection 
of 55 mg streptozotoein/kg body weight 
[freshly prepared in 0,1 M citrate buffer 
(pH 4.5), 25 mg/ml]. Time- and age-matched 
rats that did not receive STZ served as 
controls. In one series of experiments, control 
and diabetic Wistar -Munich rats were
sacrificed 11-13 days after injection. All 
diabetic animals had an increased urine 
production, glucosuria and significantly 
increased blood glucose levels (above 25 mM), 
whereas the control animals had blood 
glucose concentrations o f  about 5 mM. In 
two other series, groups of diabetic and 
control rats o f  both strains were followed
Primary deficiencies of FABP have not been for 8 months for morning blood glucose,
detected up to now. Only secondary deficiencies body weight, urine production, and albumin..
have been described. A lot of interest, however, uria (Van den Born et a l 1995). Diabetic
has evolved around the relation of FABP and animals were treated 3 times a week with a
insulin resistance. Indications have been ob- low dose (1.2 LU.) o f  bovine insulin to main-
tain blood glucose levels around 25 mM. The 
body weight o f  experimental rats was 230 g
tained for a genetic linkage on chromosome 
4 between the locus o f  the human intestinal 
FABP gene and a locus related to insulin after 8 months in contrast to 350 g for con- 
action (Prochazka et a l ,  1993). Recently, a trol rats, 
threonine-alanine substitution in the human 
intestinal FABP was found to be associated with 
increased fat oxidation in vivo and insulin ^s'says
resistance (Baier et a l , 1995). No association 
was, however, observed for the intestinal 
FABP-Thr allele with non-insulin dependent 
diabetes mellitus. Others found no evidence
Cytosols (100,000# supernatants) o f  liver, 
heart, and quadriceps muscle were prepared 
from 5% homogenates in 10 mM K-phos- 
phate/154mM KC1 (pH 7.4) as described
for a major genetic influence of the intestinal (Veerkamp and Van Moerkerk, 1986). Specific 
FABP locus on the development of non-insulin- antiscra against rat liver FABP or rat heart 
dependent diabetes mellitus (Humphreys et ai., FABP type were used to determine the cyto-
1994).
The effect of insulin-dependent diabetes on 
FABP content has been studied in investigations
solie FABP content by ELISA in liver, and 
heart and quadriceps muscle, respectively 
(Pauiussen et a l ,  1989). The antibodies were
on separate rat tissues (Brandes and Arad, 1993; coupled to horseradish peroxidase (Nakane
Carey et al,, 1994; Glatz et a l,  1994), but never 
in comparative investigations in combination 
with fatty acid oxidation capacity and in
and Kawaoi, 1974). Total and peroxisomal 
fatty acid oxidation rates were determined 
in tissue homogenates in the absence and
long-term diabetes. In this study, we report presence o f I0//M  rotenone/36/iM  antimycin
observations on the effect of 2 weeks' streptozo- 
tocin-induced diabetes on the fatty oxidation 
capacity and the FABP content of rat liver, 
heart and skeletal muscle. We also investigated 
the FABP content in these rat tissues after 8 
months of diabetes, to look for long-term 
effects.
MATERIALS AND METHODS
Animals and experimental design
After an overnight last, male Wistar- 
Munich or Lewis rats (160-180 g body
A, respectively. The substrate was 120/iM  
[ l- ,4C]palniitate bound to albumin (molar 
ratio 5:1). Other details were previously given 
(Veerkamp and Van Moerkerk, 1986). 
Citrate synthase activity was measured ac­
cording to the procedure of Shepherd and 
Garland (1969) in sonicated homogenates. 
Protein content of cytosols was determined 
according to Lowry et a l  (1951) with bovine 
serum albumin as standard. The FABP stan­
dards in ELISA are based on quantitative 
amino acid analysis. All data are expressed as 
means 4- SD.
Diabetes, fatty acid oxidation and fatty acid-binding proteins
Table 1. Eflecl of diabetes on fatty acid oxidation capacity, citrate synthase activity, and FABP content
of rat tissues
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Tissue Condition
Palmitate oxidation
rate
(nmol/min.g)
Citrate synthase 
activity
(mU/g)
FABP 
content 
(nmol/mg protein)
Liver diabetic 630 +  184* 22.7 ±1.1* 0,92 +  0.15*
control 331 ± 6 7 15.5 ±  2.1 1.52 ±  0.17
Heart diabetic 1117 ±  122 111+ 9 1.42 ±0.10*
control 948 ±  288 III ± 8 0.70 ±0 .12
M. quadriceps diabetic 156 ± 2 2 16.1 ±  1.2 0.73 ±0.08
-
control 122 ± 3 6 20.3 ± 3 ,9 0.81 ±0 .08
Assays were performed 11-13 days after injection of streptozotocin (55 mg/kg). Values are mean ±  SD 
for six animals,
*/> < 0.01.
RESULTS diabetic rats. Quadriceps muscle did not exhibit
Diabetes was confirmed by measurement of a «gnificant change of FABP content. After 8 
glucosuria and blood glucose levels. Diabetic months ,of diabetes the two investigated rat
animals sacrificed after 11-13 days o f  streptozo­
tocin injection showed less increase of body 
weight in spite of higher food intake. This 
period was taken to obtain a stable metabolic 
state. A period of 8 months was taken to 
observe the effects of chronic diabetes as in man. 
In this longitudinal study diabetic animals 
showed marked renal pathology (Van den Born 
el aU  1^95),
strains showed similar changes of the FABP 
content in liver and heart, but no change in 
skeletal muscle (Table 2). The effects were, 
however, less than those after 11-13 days, due to 
changes o f  the control values. These changes are 
presumably related to maturation and ageing.
DISCUSSION
Diabetes like fasting causes a marked increase
Our data for control rats are in accordance of mitochondrial fatty acid oxidation in per-
with previous results (Paulussen et a l , 1989; 
Vcerkamp and Van Moerkcrk, 1986). The total
fused rat liver (McGarry et a l 1975), hepato- 
cytes (Witters and Trasko, 1979), liver 
palmitate oxidation capacity measured in liver homogenates (MacDonald and Swan, 1992; this 
homogenates showed a 90% increase in the work) and mitochondria (Harano et al., 1972).
11 13 days diabetic rats (Table 1). Simul- An increase of the carnitine palmitoyltrans- 
taneously, the citrate synthase activity increased ferase I activity (Brady et a l , 1985; Cook and 
by 46% and the peroxisomal (antimycin-insensi- Gamble, 1987; Harano et a l , 1972), a decrease
tive) oxidation rate (data not presented) by of its malonyl-CoA sensitivity (Brady et a l ,
only 15 ± 4 % . This indicates that the volume 1985; Cook and Gamble, 1987) and a decrease
and/or number of mitochondria and the specific of malonyl-CoA concentration (McGarry et a l ,
mitochondrial fatty acid oxidation rate (rate per 1978) are the main factors responsible for this
U citrate synthase) are higher in the diabetic rat 
liver. The palmitate oxidation rates and the 
citrate synthase activity did not change signifi­
cantly in heart and quadriceps muscle of
phenomenon. Peroxisomal fatty acid oxidation 
increased only slightly like in starvation 
(Veerkamp and Van Moerkerk, 1986), in con­
trast to mitochondrial oxidation. Others found
diabetic rats (Table 1). The FABP content of the a 1.3-fold and no increase of peroxisomal oxi- 
tissue cytosols showed a marked decrease for dation in rat liver after 10-21 days of diabetes 
liver and a 100% increase for heart of 11-13 day (Kawashima et a l , 1983; Thomas et a l , 1989).
Table 2. Effect of chronic diabetes on FABP content of rat tissues
Strain Condition Liver Heart M. quadriceps
Wistar Miinich
Lewis
diabetic (5-13) 
control (5) 
diabetic (7) 
control (4)
0.83 ±0.16  
0.90 ±  0.02 
0.65 +  0,07** 
1.08 ±0.09
1.70 ±  0.11* 
1.47 ±0 .16  
1.59 ±0.13*  
1.34 ± 0 .16
0.71 ±0 .12  
0.72 ±  0.09 
0.71 ±0.05*  
0.62 ±0.08
The period of streptozolocin-induced diabetes was 8 months.
Values (mean ±  SD) are given in nmol/mg cytosolic protein for the number of rats indicated
between parenthesis.
*P <0.05, **/> <0.01.
lie .is -I I.
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(Brandes and Arad, 1983; Nakagawa et a l ,
1994), to a comparable extent (by 52%) as in 
our diabetic rats. A correlation was observed 
between the level of hepatic FABP and the 
incorporation o f  [l4C]oleic acid into triacylgly-
cerol for control, diabetic and adrenalectomized 
rats (Nakagawa et a l ,  1994). The 40% decrease 
of liver FABP at an increase of fatty acid 
oxidation capacity by 90%) in diabetic rat liver 
is in contrast with the slight (2%) decrease of 
FABP content at an increase of fatty acid 
oxidation capacity by 72%) in starved rat liver 
(Veerkamp and Van Moerkerk, 1986). High-fat 
diet and peroxisomal prolifcrators enhance both 
liver FABP content and fatty acid oxidation 
(Veerkamp and Van Moerkerk, 1993). These 
data strengthen previous conclusions that 
FABP is involved in liver in more processes of 
fatty acid metabolism than fatty acid oxidation 
(e.g. synthesis of iriacylglycerols, phospholipids 
and eicosanoids), and presumably also acts as a 
[14C]palmitate was increased in incubated more universal binding protein o f  hydrophobic 
hemidiaphragm from diabetic rats (Stearns ligands (Veerkamp et a l , 1993; Veerkamp,
Fatty acid oxidation by the heart appears to 
be unaffected by diabetes or starvation 
(Veerkamp and Van Moerkerk, 1986). The pres­
ence of chronic diabetes (6-14 weeks) had no 
effect on oxygen consumption and palmitate 
oxidation in perfused rat heart and cardiomy- 
ocytes (Chen et a/., 1984; Murthy et a l , 1990; 
Wall and Lopaschuk, 1989). Our data on the 
fatty acid oxidation capacity of heart hornogen- 
ates and the slightly increased or constant 
activity of 3-hydroxyacyl-CoA dehydrogenase 
(Chen et al., 1984; Glatz et al., 1994) are in 
accordance with these observations. Only one 
group reported an increase of myocardial fatty 
acid oxydation in diabetic rats (MacDonald 
et al., 1992). Diabetes also had no effect on the 
palmitate oxidation capacity of quadriceps 
muscle (Table 1). Others found an increase 
in diabetic rat soleus, but not in psoas and 
extensor digitorum longus muscles (MacDonald 
et al., 1992). I4C 0 2 production from
14
et al., 1979), but l4C 0 2 represents only a part of  
the 14C-labelled oxidation products at short
1995).
An increase of rat heart FABP content was
incubation periods (Veerkamp et at., 1986). also observed in rats with insulin- and with 
Acute diabetes (2-3 d) caused an increase of non-insulin-dependent diabetes mellitus (Glatz
fatty acid uptake and oxidation by skeletal et al,, 1994). The increase in the former group
muscle of dogs in vivo (Spitzer and Hori, 1969). (32%) was less than in our comparable, diabetic
3-Hydroxyacyl-CoA dehydrogenase activity animals. In contrast with results on red quadri-
increased in rat soleus, plantaris, white and red 
gastrocnemius muscles and diaphragm 10..12
ceps muscle (Carey et al., 1994) we did not find 
a marked increase of the FABP content of total
weeks after induction of diabetes (Chen and quadriceps muscle of diabetic (this report) and
Iannuzzo, 1982). The unchanged citrate syn- 1- or 3-day-starved (Paulusscn et al., 1989;
thase activity also observed by others (Chen and Veerkamp and Van Moerkerk, 1993) rats. An
Ianuzzo, 1982; Chen et a i , 1984; Glatz et a i ,  increase of FABP mRNA was observed in red
1994) indicates that the mitochondrial content quadriceps (Carey et a i,  1994), but not in heart
of heart and skeletal muscles was unaffected by and psoas muscle (Sakai et a i ,  1995) o f  diabetic
diabetes. One group reported, however, reduced rats. These differences may be related to the
activities of citrate synthase and other mito- proportion of slow oxidative fibres o f  the muscle
chondrial enzymes of rat skeletal muscles after samples, The highest concentration o f  heart
12-16 weeks of diabetes (Kainulainen et a l , 
1994). Starvation did also not change the 
palmitate oxidation capacity of rat heart
FABP type is present in heart and red skeletal 
muscles as soleus and diaphragm and its con­
centration corresponds to the proportion of
and quadriceps muscle (Veerkamp and Van slow-oxidative fibres in other muscles (Clafley 
Moerkerk, 1986) and their citrate synthase et a l , 1987; Crisman et a l , 1987; Paulusscn
activity (Caterson et a l ,  1982). et a l , 1989; Veerkamp et a l ,  1990; Vork et al,
The FABP content is influenced by hormonal 1991). In these muscle cells, FABP expression
conditions, especially in the liver. Gonadal appears to be induced by diabetes, but this
hormones, glucocorticoids, thyroid hormones induction is not accompanied by an increase of
and insulin regulate liver FABP level (Brandes the mitochondrial capacity of citrate synthase
and Arad, 1983; Nakagawa*?/ a l , 1994; Ockner activity and fatty acid oxidation.
et a l , 1979). The FABP content in rat liver 
cytosol measured by oleic acid binding was 
decreased in streptozotocin-diabetes rates
Fatty acids induce the expression o f  adipocyte 
FABP in vitro (Amri et a l , 1991), This molecule 
may be involved in the fatty acid flux into the
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adipocyte during feeding (lipogenic conditions) 
and out of this cell during fasting (lipolytic) 
conditions. Although streptozotocin-induced 
diabetes is characterized by an increase in fatty 
acid mobilization and a loss of triacylglycerol 
stores in rat adipose tissue, it caused a large 
decrease in the transcription o f  the adipocyte 
FA BP and in the levels of adipocyte FABP 
m RNA and protein (Melki and Abumrad, 
1993). These changes were suggested to be 
related to insulin deficiency generating a cellular 
state similar to that of the preadipocyte. About 
other tissues few data is known on the effect of  
diabetes on FABP. The levels of heart type 
FABP and its m RNA are significantly decreased 
in aorta, but the heart FABP m RNA level was 
the same in kidney of streptozotocin-diabetic 
rats (Sakai et al., 1995).
In conclusion, streptozotocin-induced in­
sulin-dependent diabetes mellitus causes 
changes o f  FABP content which do not corre­
lated with changes of fatty acid oxidation 
capacity in rat liver, heart and skeletal muscle or 
of lipolysis in rat adipose tissue. The absence of  
a correlation suggests FABP is not playing a 
direct role in regulation o f fatty acid oxidation 
during diabetes. Clearly these studies do not 
rule out functions for FABPs in other pathways
of lipid metabolism, e.g. synthesis o f  triaeylgly- 
cerols, phospholipids and eicosanoids. In 
addition, they may modulate the effect of fatty 
acids on metabolic enzymes, ion channels and
I I
gene activity.
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